Transcend Capital Advisors, LLC Johnson & Johnson Transaction History

Transcend Capital Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 64,099 shares of JNJ stock, worth $9.95 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

64,099

Previous 73,193 12.42%

Holding current value

$9.95 Million

Previous $10.7 Million 2.9%

% of portfolio

0.72%

Previous 0.79%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$145.48 - $167.38 $1.32 Million - $1.52 Million	-9,094 Reduced 12.42%	64,099 $10.4 Million
Q2 2024 Jul 02, 2024	SELL	$144.38 - $157.78 $4.32 Million - $4.73 Million	-29,950 Reduced 29.04%	73,193 $10.7 Million
Q1 2024 May 03, 2024	SELL	$155.22 - $162.74 $105,394 - $110,500	-679 Reduced 0.65%	103,143 $16.3 Million
Q4 2023 Feb 05, 2024	SELL	$145.6 - $158.88 $1.28 Million - $1.4 Million	-8,814 Reduced 7.83%	103,822 $16.3 Million
Q3 2023 Oct 31, 2023	BUY	$155.75 - $174.48 $9.45 Million - $10.6 Million	60,704 Added 116.89%	112,636 $17.5 Million
Q2 2023 Jul 13, 2023	SELL	$154.35 - $166.11 $1.19 Million - $1.28 Million	-7,701 Reduced 12.91%	51,932 $8.6 Million
Q1 2023 Apr 12, 2023	BUY	$151.05 - $180.26 $669,000 - $798,371	4,429 Added 8.02%	59,633 $9.24 Million
Q4 2022 Jan 20, 2023	BUY	$160.2 - $179.79 $294,607 - $330,633	1,839 Added 3.45%	55,204 $0
Q3 2022 Oct 17, 2022	BUY	$161.33 - $179.52 $31,298 - $34,826	194 Added 0.36%	53,365 $8.72 Million
Q2 2022 Jul 12, 2022	BUY	$168.19 - $186.01 $358,244 - $396,201	2,130 Added 4.17%	53,171 $9.44 Million
Q1 2022 Apr 20, 2022	SELL	$158.14 - $179.59 $173,005 - $196,471	-1,094 Reduced 2.1%	51,041 $9.05 Million
Q4 2021 Jan 20, 2022	BUY	$155.93 - $173.01 $602,825 - $668,856	3,866 Added 8.01%	52,135 $8.92 Million
Q3 2021 Nov 04, 2021	SELL	$161.5 - $179.47 $152,294 - $169,240	-943 Reduced 1.92%	48,269 $8 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $1.34 Million - $1.43 Million	8,386 Added 20.54%	49,212 $8.1 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $94,291 - $105,015	-616 Reduced 1.49%	40,826 $6.71 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $1.62 Million - $1.86 Million	11,830 Added 39.95%	41,442 $6.52 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $633,675 - $694,388	4,514 Added 17.99%	29,612 $4.41 Million
Q2 2020 Aug 05, 2020	SELL	$128.81 - $155.51 $462,041 - $557,814	-3,587 Reduced 12.5%	25,098 $3.53 Million
Q1 2020 May 08, 2020	SELL	$111.14 - $153.99 $103,582 - $143,518	-932 Reduced 3.15%	28,685 $3.77 Million
Q4 2019 Feb 19, 2020	BUY	$127.5 - $146.44 $3.78 Million - $4.34 Million	29,617 New	29,617 $4.32 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Johnson & Johnson Transaction History